Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2023 Jul 1;47(3):146-154.
doi: 10.1097/NPT.0000000000000440. Epub 2023 Apr 4.

Natural Walking Intensity in Persons With Parkinson Disease

Affiliations
Observational Study

Natural Walking Intensity in Persons With Parkinson Disease

Jaimie L Girnis et al. J Neurol Phys Ther. .

Abstract

Background and purpose: Few persons with Parkinson disease (PD) appear to engage in moderate-intensity walking associated with disease-modifying health benefits. How much time is spent walking at lower, yet still potentially beneficial, intensities is poorly understood. The purpose of this exploratory, observational study was to describe natural walking intensity in ambulatory persons with PD.

Methods: Accelerometer-derived real-world walking data were collected for more than 7 days at baseline from 82 participants enrolled in a PD clinical trial. Walking intensity was defined according to the number of steps in each active minute (1-19, 20-39, 40-59, 60-79, 80-99, or ≥100 steps). Daily minutes of walking and duration of the longest sustained walking bout were calculated at each intensity. Number of sustained 10 to 19, 20 to 29, and 30-minute bouts and greater at any intensity also were calculated. Values were analyzed in the context of physical activity guidelines.

Results: Most daily walking occurred at lower intensities (157.3 ± 58.1 min of 1-19 steps; 81.3 ± 32.6 min of 20-39 steps; 38.2 ± 21.3 min of 40-59 steps; 15.1 ± 11.5 min of 60-79 steps; 7.4 ± 7.0 min of 80-99 steps; 7.3 ± 9.6 min of ≥100 steps). The longest daily sustained walking bout occurred at the lowest intensity level (15.9 ± 5.2 min of 1-19 steps). Few bouts lasting 20 minutes and greater occurred at any intensity.

Discussion and conclusions: Despite relatively high daily step counts, participants tended to walk at remarkably low intensity, in bouts of generally short duration, with relatively few instances of sustained walking. The findings reinforced the need for health promotion interventions designed specifically to increase walking intensity.Video Abstract available for more insight from authors (see the Video, Supplemental Digital Content 1 available at: http://links.lww.com/JNPT/A426 ).

Trial registration: ClinicalTrials.gov NCT03517371.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1:
Figure 1:
Mean (95% CI) daily minutes of walking activity at each intensity level (n = 82). Values were calculated based on seven days of recording.
Figure 2:
Figure 2:
Mean (95% CI) daily minutes of walking activity at each intensity level for more active (n = 39) and less active (n = 43) subgroups. Values were calculated based on seven days of recording (Panel a) and the most active three days of recording (Panel b).
Figure 3:
Figure 3:
Duration in minutes of longest daily bout (95% CI) of sustained walking at each intensity level for the more active (n = 39) and less active (n = 43) subgroups. Values were calculated based on seven days of recording (Panel a) and the most active three days of recording (Panel b).

References

    1. Balestrino R, Schapira AHV. Parkinson disease. Eur J Neurol. 2020;27(1):27–42. doi:10.1111/ene.14108 - DOI - PubMed
    1. Bloem BR, Okun MS, Klein C. Parkinson’s disease. Lancet. 2021;397(10291):2284–2303. doi:10.1016/S0140-6736(21)00218-X - DOI - PubMed
    1. Christiansen C, Moore C, Schenkman M, et al. Factors associated with ambulatory activity in De Novo Parkinson disease. J Neurol Phys Ther. 2017;41(2):93–100. doi:10.1097/NPT.0000000000000169 - DOI - PMC - PubMed
    1. Ellis TD, Cavanaugh JT, Earhart GM, et al. Identifying clinical measures that most accurately reflect the progression of disability in Parkinson disease. Parkinsonism Relat Disord. 2016;25:65–71. doi:10.1016/j.parkreldis.2016.02.006 - DOI - PubMed
    1. Shulman LM. Understanding disability in Parkinson’s disease. Mov Disord. 2010;25 Suppl 1:S131–S135. doi:10.1002/mds.22789 - DOI - PubMed

Publication types

Associated data